Noom Introduces GLP-1 Drug Option in Innovative Weight Loss Program

Noom, a digital health company, has announced a new weight loss product featuring a compounded GLP-1 drug starting at $149. The treatment includes compounded semaglutide, the same active ingredient in

Detail